Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience
| Image |  |
|---|---|
| Description | scientific article published on 12 March 2019 |
| Author/s |
author: Osnat Bairey Yair Herishanu Tamar Tadmor Lev Shvidel |
| Publication date | March 12, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |